Sunday 18 October 2026
Export DYNTQ’s income statement to Excel — free account
Dynatronics Corporation
DYNTQ Healthcare Medical Devices
Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024. In the quarter to September 2025, revenue fell 7.61%, EPS grew 66.7% and free cash flow fell 193.0%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow DYNTQ
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 3 | 3 |
| (50.72%) | (64.70%) | (1,588.36%) | (2,563.17%) | ||
| (11.60%) | (13.78%) | (56.08%) | (57.18%) | ||
ROIC |
(8.10%) | (10.20%) | (25.59%) | (24.36%) | |
Return on Tangible Assets |
(88.58%) | (125.60%) | (519.88%) | (573.14%) | |
Average Days of Receivables |
36.95 | 38.72 | 39.80 | 37.82 | |
Free Cash Flow per Share |
(0.01) | 0.05 | 0.03 | 0.01 | |
Free Cash Flow |
(0.07) | 0.42 | 0.27 | 0.08 | |
Capital Expenditures |
(0.22) | (0.04) | (0.03) | (0.03) | |
| Other line items | |||||
Cash ROIC |
(0.41%) | 2.73% | 3.97% | 1.01% | |
Accounts Receivable Turnover |
8.26 | 7.89 | 7.96 | 8.45 | |
Accounts Payable Turnover |
6.13 | 6.06 | 6.99 | 7.13 | |
Inventory Turnover |
3.43 | 3.78 | 4.01 | 4.09 | |
Average Days of Payables |
55.44 | 61.34 | 58.11 | 54.92 | |
Days of Inventory on Hand |
104.67 | 90.64 | 86.62 | 83.64 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
30.68% | 31.08% | 30.90% | 30.03% | |
Share Based Compensation of Revenue |
(0.04%) | 0.02% | 0.01% | 0.01% | |
Interest Coverage |
(4.63) | (5.65) | (5.99) | (5.63) | |
Operating CF/Net income |
(0.05) | (0.13) | (0.03) | (0.01) | |
Depreciation/Fixed assets |
0.63 | 0.62 | 5.33 | 5.67 | |
Capex/Depreciation |
(0.20) | (0.04) | 0.00 | 0.00 | |
Revenue per Share |
4.13 | 3.23 | 3.37 | 2.06 | |
Operating CF per Share |
0.02 | 0.05 | 0.04 | 0.01 | |
Capex per Share |
(0.03) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 |
Columns are period end dates